Highlights on Future Treatments of IPF: Clues and Pitfalls
International Journal of Molecular Sciences · 01.08.2024 · 25 (15) · 8392
DOI: 10.3390/ijms25158392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.08.2024. Verfasst von Alessandro Libra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico "G. Rodolico-San Marco", University of …. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by irreversible scarring of lung tissue, leading to death. Despite recent advancements in understanding its pathophysiology, IPF remains elusive, and therapeutic options are limited and non-curative. This review aims to synthesize the latest research developments, focusing on the molecular mechanisms driving the disease and on the related emerging treatments. Unfortunately, several phase 2 studies showing promising preliminary results did not meet the primary endpoints in the subsequent phase 3, underlying the complexity of the disease and the need for new integrated endpoints. IPF remains a challenging condition with a complex interplay of genetic, epigenetic, and pathophysiological factors. Ongoing research into the molecular keystones of IPF is critical for the development of targeted therapies that could potentially stop the progression of the disease. Future directions include personalized medicine approaches, artificial intelligence integration, growth in genetic insights, and novel drug targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico "G. Rodolico-San Marco", University of Catania, 95123 Catania, CT, Italy.
- Artroreuma s.r.l., Rheumatology Outpatient Clinic, 95030 Mascalucia, CT, Italy.
ORCID-Profile: Alessandro Libra, Giuseppe Muscato, Gianluca Sambataro, Lucia Spicuzza, Carlo Vancheri
Zitieren
APA
Libra, A., Sciacca, E., Muscato, G., Sambataro, G., Spicuzza, L., & Vancheri, C. (2024). Highlights on Future Treatments of IPF: Clues and Pitfalls. International Journal of Molecular Sciences, 25(15), 8392. https://doi.org/10.3390/ijms25158392
Vancouver
Libra A, Sciacca E, Muscato G, Sambataro G, Spicuzza L, Vancheri C. Highlights on Future Treatments of IPF: Clues and Pitfalls. International Journal of Molecular Sciences. 2024;25(15):8392. doi:10.3390/ijms25158392
BibTeX
@article{Libra2024,
author = {Libra, Alessandro and Sciacca, Enrico and Muscato, Giuseppe and Sambataro, Gianluca and Spicuzza, Lucia and Vancheri, Carlo},
title = {Highlights on Future Treatments of IPF: Clues and Pitfalls},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {15},
pages = {8392},
doi = {10.3390/ijms25158392}
}
EUVIMED